These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11305702

  • 1. Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.
    Agid O, Shalev AY, Lerer B.
    J Clin Psychiatry; 2001 Mar; 62(3):169-73. PubMed ID: 11305702
    [Abstract] [Full Text] [Related]

  • 2. Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation.
    Agid O, Lerer B.
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):41-9. PubMed ID: 12899735
    [Abstract] [Full Text] [Related]

  • 3. T3 augmentation of SSRI resistant depression.
    Abraham G, Milev R, Stuart Lawson J.
    J Affect Disord; 2006 Apr; 91(2-3):211-5. PubMed ID: 16483669
    [Abstract] [Full Text] [Related]

  • 4. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [Abstract] [Full Text] [Related]

  • 5. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
    Smajkic A, Weine S, Djuric-Bijedic Z, Boskailo E, Lewis J, Pavkovic I.
    J Trauma Stress; 2001 Jul; 14(3):445-52. PubMed ID: 11534876
    [Abstract] [Full Text] [Related]

  • 6. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
    Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.
    J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
    [Abstract] [Full Text] [Related]

  • 7. Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy.
    Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, Agbor-Tabi D, Huber M, Wang Z.
    J Clin Psychopharmacol; 2019 Aug; 39(2):153-157. PubMed ID: 30640209
    [Abstract] [Full Text] [Related]

  • 8. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.
    Appelhof BC, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Huyser J, Schene AH, Tijssen JG, Wiersinga WM.
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6271-6. PubMed ID: 15579788
    [Abstract] [Full Text] [Related]

  • 9. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH.
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L, Berk M, Vorster M.
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [Abstract] [Full Text] [Related]

  • 11. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.
    Ostroff RB, Nelson JC.
    J Clin Psychiatry; 1999 Apr; 60(4):256-9. PubMed ID: 10221288
    [Abstract] [Full Text] [Related]

  • 12. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD.
    J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
    [Abstract] [Full Text] [Related]

  • 13. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [Abstract] [Full Text] [Related]

  • 14. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.
    J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
    [Abstract] [Full Text] [Related]

  • 15. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study.
    Smith WT, Londborg PD, Glaudin V, Painter JR.
    Am J Psychiatry; 1998 Oct; 155(10):1339-45. PubMed ID: 9766764
    [Abstract] [Full Text] [Related]

  • 16. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
    Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.
    Arch Gen Psychiatry; 2006 Oct; 63(10):1158-65. PubMed ID: 17015818
    [Abstract] [Full Text] [Related]

  • 17. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
    Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH.
    J Clin Psychiatry; 2008 Mar; 69(3):400-5. PubMed ID: 18348595
    [Abstract] [Full Text] [Related]

  • 18. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.
    Depress Anxiety; 2008 Mar; 25(1):46-54. PubMed ID: 17149753
    [Abstract] [Full Text] [Related]

  • 19. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 20. Personality change during depression treatment: a placebo-controlled trial.
    Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam J, Shelton R, Schalet B.
    Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.